199 related articles for article (PubMed ID: 8820417)
21. The dependence of the incorporation of methamphetamine into rat hair on dose, frequency of administration and hair pigmentation.
Han E; Park Y; Kim E; Lee S; Choi H; Chung H; Song JM
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2845-51. PubMed ID: 20863772
[TBL] [Abstract][Full Text] [Related]
22. Hair opiates during pain treatment.
Goullé JP; Noyon J; Bietry F; Patricot B; Roumajon A; Bouige D
Forensic Sci Int; 1997 Jan; 84(1-3):137-44. PubMed ID: 9042718
[TBL] [Abstract][Full Text] [Related]
23. Concentration ratios of codeine-to-morphine in plasma after a single oral dose (100 mg) of codeine phosphate.
Kronstrand R; Jones AW
J Anal Toxicol; 2001 Sep; 25(6):486-7. PubMed ID: 11550826
[No Abstract] [Full Text] [Related]
24. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
Dunnick J
Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
[TBL] [Abstract][Full Text] [Related]
25. Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels.
Bhargava HN; Villar VM; Gulati A; Chari G
J Pharmacol Exp Ther; 1991 Aug; 258(2):511-6. PubMed ID: 1865354
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics and tolerance development during multiple intravenous bolus morphine administration in rats.
Ouellet DM; Pollack GM
J Pharmacol Exp Ther; 1997 May; 281(2):713-20. PubMed ID: 9152377
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
28. Determination of opiates in serum, saliva and hair addicted persons.
Piekoszewski W; Janowska E; Stanaszek R; Pach J; Winnik L; Karakiewicz B; Kozielec T
Przegl Lek; 2001; 58(4):287-9. PubMed ID: 11450354
[TBL] [Abstract][Full Text] [Related]
29. Concentrations of unconjugated morphine, codeine and 6-acetylmorphine in urine specimens from suspected drugged drivers.
Ceder G; Jones AW
J Forensic Sci; 2002 Mar; 47(2):366-8. PubMed ID: 11908609
[TBL] [Abstract][Full Text] [Related]
30. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.
Okura T; Morita Y; Ito Y; Kagawa Y; Yamada S
J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997
[TBL] [Abstract][Full Text] [Related]
31. Intravenous self-administration of morphine and cocaine: a comparative study.
Mierzejewski P; Koroś E; Goldberg SR; Kostowski W; Stefański R
Pol J Pharmacol; 2003; 55(5):713-26. PubMed ID: 14704467
[TBL] [Abstract][Full Text] [Related]
32. History of cocaine self-administration alters morphine reinforcement in the rat.
Mierzejewski P; Stefanski R; Bienkowski P; Kostowski W
Eur J Pharmacol; 2007 May; 562(1-2):77-81. PubMed ID: 17336286
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
34. The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administration.
Ropero-Miller JD; Goldberger BA; Cone EJ; Joseph RE
J Anal Toxicol; 2000 Oct; 24(7):496-508. PubMed ID: 11043652
[TBL] [Abstract][Full Text] [Related]
35. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
36. Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration.
Quiding H; Anderson P; Bondesson U; Boréus LO; Hynning PA
Eur J Clin Pharmacol; 1986; 30(6):673-7. PubMed ID: 3770062
[TBL] [Abstract][Full Text] [Related]
37. Modulation of endogenous opiate production: effect of fasting.
Molina PE; Hashiguchi Y; Meijerink WJ; Naukam RJ; Boxer R; Abumrad NN
Biochem Biophys Res Commun; 1995 Feb; 207(1):312-7. PubMed ID: 7857282
[TBL] [Abstract][Full Text] [Related]
38. Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics.
Findlay JW; Jones EC; Butz RF; Welch RM
Clin Pharmacol Ther; 1978 Jul; 24(1):60-8. PubMed ID: 657721
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteers.
Guay DR; Awni WM; Halstenson CE; Findlay JW; Opsahl JA; Abraham PA; Jones EC; Matzke GR
J Clin Pharmacol; 1987 Dec; 27(12):983-7. PubMed ID: 3437070
[TBL] [Abstract][Full Text] [Related]
40. Disposition of codeine in female human hair after multiple-dose administration.
Wilkins DG; Haughey HM; Krueger GG; Rollins DE
J Anal Toxicol; 1995 Oct; 19(6):492-8. PubMed ID: 8926744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
